These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 6973392)

  • 1. Differences in antibody-dependent cellular cytotoxicity and activated killing of tumor cells by macrophage cell lines.
    Ralph P; Nakoinz I
    Cancer Res; 1981 Sep; 41(9 Pt 1):3546-50. PubMed ID: 6973392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line.
    Meltzer MS; Benjamin WR; Farrar JJ
    J Immunol; 1982 Dec; 129(6):2802-7. PubMed ID: 6982943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.
    Crawford RM; Finbloom DS; Ohara J; Paul WE; Meltzer MS
    J Immunol; 1987 Jul; 139(1):135-41. PubMed ID: 3108395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-dependent killing of erythrocyte and tumor targets by macrophage-related cell lines: enhancement by PPD and LPS.
    Ralph P; Nakoinz I
    J Immunol; 1977 Sep; 119(3):950-54. PubMed ID: 894031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy.
    Han X; Wilbanks GD; Devaja O; Ruperelia V; Raju KS
    Gynecol Oncol; 1999 Nov; 75(2):198-210. PubMed ID: 10525372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct signals for antibody-dependent and nonspecific killing of tumor targets mediated by macrophages.
    Ralph P; Williams N; Nakoinz I; Jackson H; Watson JD
    J Immunol; 1982 Jul; 129(1):427-32. PubMed ID: 7045225
    [No Abstract]   [Full Text] [Related]  

  • 8. Ex vivo-activated human macrophages kill chronic lymphocytic leukemia cells in the presence of rituximab: mechanism of antibody-dependent cellular cytotoxicity and impact of human serum.
    Lefebvre ML; Krause SW; Salcedo M; Nardin A
    J Immunother; 2006; 29(4):388-97. PubMed ID: 16799334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-dependent cellular cytotoxicity against tumor cells. II. The promonocyte identified as effector cell.
    Domzig W; Lohmann-Matthes ML
    Eur J Immunol; 1979 Apr; 9(4):267-72. PubMed ID: 467490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ability of lymphokine and lipopolysaccharide to induce procoagulant activity in mouse macrophage cell lines.
    Farram E; Geczy CL; Moon DK; Hopper K
    J Immunol; 1983 Jun; 130(6):2750-6. PubMed ID: 6602180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of C1q biosynthesis suppress activation of murine macrophages for both antibody-independent and antibody-dependent tumor cytotoxicity.
    Leu RW; Zhou AQ; Shannon BJ; Herriott MJ
    J Immunol; 1990 Mar; 144(6):2281-6. PubMed ID: 2107257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of macrophage-induced cytotoxicity by phorbol ester tumor promoters.
    Laskin DL; Laskin JD; Kessler FK; Weinstein IB; Carchman RA
    Cancer Res; 1981 Nov; 41(11 Pt 1):4523-8. PubMed ID: 7306973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage activation to kill Leishmania tropica: characterization of a T cell-derived factor that suppresses lymphokine-induced intracellular destruction of amastigotes.
    Nacy CA
    J Immunol; 1984 Jul; 133(1):448-53. PubMed ID: 6202789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage tumoricidal activity induced by human C-reactive protein.
    Zahedi K; Mortensen RF
    Cancer Res; 1986 Oct; 46(10):5077-83. PubMed ID: 3489521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures.
    Ruco LP; Meltzer MS
    J Immunol; 1977 Sep; 119(3):889-96. PubMed ID: 330759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of murine leukemia virus env gene proteins on macrophage-mediated cytotoxicity in vitro.
    Chapes SK; Takemoto LJ
    Life Sci Adv; 1991; 10():9-21. PubMed ID: 11538406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
    Neville ME; Hiserodt JC
    J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic functions and in vitro activation of cultured macrophage tumor lines.
    Ralph P; Nakoinz I; Broxmeyer HE; Schrader S
    Natl Cancer Inst Monogr; 1978 May; (48):303-10. PubMed ID: 107454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
    Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
    Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.
    Taramelli D; Varesio L
    J Immunol; 1981 Jul; 127(1):58-63. PubMed ID: 6787132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.